Skip to main content
GutCited

락토바실루스 플란타룸 그림

4 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1 Forest Plot

Forest plot summarizing the pooled efficacy of probiotic interventions across multiple gastrointestinal conditions, with odds ratios and confidence intervals for each included trial.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 2
Figure 2 Forest Plot

Subgroup analysis by probiotic strain type reveals differential efficacy, with Lactobacillus and Saccharomyces species showing the strongest associations with symptom improvement.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 4
Figure 4 Forest Plot

Stratified forest plot examining probiotic efficacy specifically in antibiotic-associated diarrhea trials shows a significant protective effect compared to placebo.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 5
Figure 5 Forest Plot

Sensitivity analysis removing individual studies demonstrates that the overall positive association between probiotic supplementation and gastrointestinal symptom relief remains robust.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.